Prestige Consumer Healthcare (PBH) Depreciation & Amortization - Total (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Depreciation & Amortization - Total of $2.4 million in Q4 2025, down 1.97% quarter-over-quarter from $2.5 million in Q3 2025, and up 28.04% on a YoY basis from $1.9 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Depreciation & Amortization - Total (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Depreciation & Amortization - Total history runs 15 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- In Q4 2025, Depreciation & Amortization - Total rose 28.04% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $10.4 million (up 16.75% YoY), while the FY2025 annual figure was $9.7 million, up 18.29% from the prior year.
- Depreciation & Amortization - Total was $2.4 million for Q4 2025 at Prestige Consumer Healthcare, down from $2.5 million in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $3.9 million in Q1 2021 to a low of $1.8 million in Q3 2021.
- Historically, Depreciation & Amortization - Total has averaged $2.2 million across 5 years, with a median of $2.0 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization - Total surged 261.34% in 2021, then sank 54.43% in 2022.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $1.8 million in 2021, then climbed by 3.6% to $1.9 million in 2022, then grew by 7.38% to $2.0 million in 2023, then fell by 5.03% to $1.9 million in 2024, then climbed by 28.04% to $2.4 million in 2025.
- The last three Depreciation & Amortization - Total figures came in at $2.4 million (Q4 2025), $2.5 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.33 Bn | 2.26 Bn | 157.37 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.94 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 1.79 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Mar 31, 2021 | 3.94 Mn |